Kannan Krishnamurthy is an Associate Director, Technology Development in the Office of Technology Development (OTD). He supervises a team that includes OTD’s Immunotherapy Project Manager. Additionally, he is Memorial Sloan Kettering’s representative on the Technology Transfer Committee (TTC) of the Parker Institute for Cancer Immunotherapy (PICI). In this role, he and his counterparts from the other PICI consortium members on the TTC are responsible for management and commercialization of intellectual property developed by PICI researchers.
Previously, he served as OTD’s Senior Manager, Business Development & Licensing. Kannan joined the OTD in May 2012 in the newly created role of Licensing Assistant, and he became a Licensing Manager the following year. Previously, Kannan was a postdoctoral fellow at Cold Spring Harbor Laboratory, where he studied the interaction between oncogenes and cell polarity pathways and its relevance to breast cancer. In addition, he carried out preclinical testing of a new class of inhibitors in a mouse model of breast cancer to evaluate toxicity and efficacy.
Kannan received his PhD degree in cell and developmental biology from the Medical College of Georgia in 2009. His prior research experience includes an internship at Eli Lilly and Company. Kannan obtained a Master of Science degree in biochemistry from M.S. University of Baroda, in India.